|
MAN2A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.402800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.078580E-03 |
| Normal-vs-Stage2 |
7.679800E-01 |
| Normal-vs-Stage3 |
2.961000E-03 |
| Normal-vs-Stage4 |
7.471400E-01 |
| Stage1-vs-Stage2 |
1.528020E-01 |
| Stage1-vs-Stage3 |
6.792000E-01 |
| Stage1-vs-Stage4 |
5.908800E-01 |
| Stage2-vs-Stage3 |
1.437030E-01 |
| Stage2-vs-Stage4 |
8.702000E-01 |
| Stage3-vs-Stage4 |
4.931200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.321800E-03 |
| Normal-vs-AfricanAmerican |
1.310600E-01 |
| Normal-vs-Asian |
7.422900E-04 |
| Caucasian-vs-AfricanAmerican |
4.367800E-01 |
| Caucasian-vs-Asian |
2.179600E-01 |
| AfricanAmerican-vs-Asian |
1.768220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.782600E-04 |
| Normal-vs-Female |
8.248200E-01 |
| Male-vs-Female |
1.278210E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.168000E-02 |
| Normal-vs-Extreme_Weight |
2.717600E-03 |
| Normal-vs-Obese |
1.435840E-01 |
| Normal-vs-Extreme_Obese |
1.415860E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.687600E-01 |
| Normal_Weight-vs-Obese |
4.302600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.572600E-01 |
| Extreme_Weight-vs-Obese |
2.276600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.847800E-01 |
| Obese-vs-Extreme_Obese |
1.932190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.485700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.734010E-01 |
| Normal-vs-Age(61-80Yrs) |
4.168000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.327800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.062400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.137800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.863800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.435700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.285000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.483000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.498200E-02 |
| Normal-VS-Type2 PRCC |
1.85249999999915E-05 |
| Normal-VS-KIRP CIMP |
8.768400E-01 |
| Normal-VS-Unclassified PRCC |
3.744000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.117880E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.137000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.781400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.998480E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.898170E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.315000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.62159999999423E-05 |
| Normal-vs-N1 |
2.441600E-01 |
| Normal-vs-N2 |
9.927400E-01 |
| N0-vs-N1 |
1.998990E-01 |
| N0-vs-N2 |
5.510600E-01 |
| N1-vs-N2 |
6.487000E-01 |
|
|
